SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-275815
Filing Date
2022-11-02
Accepted
2022-11-02 16:05:03
Documents
4
Period of Report
2022-11-02

Document Format Files

Seq Description Document Type Size
1 6-K d409201d6k.htm 6-K 9653
2 EX-99.1 d409201dex991.htm EX-99.1 101273
3 GRAPHIC g409201page001.jpg GRAPHIC 12614
4 GRAPHIC g409201page002.jpg GRAPHIC 6978
  Complete submission text file 0001193125-22-275815.txt   139186
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 221353969
SIC: 2834 Pharmaceutical Preparations